A Study of [14C]-LY3537982 in Healthy Participants
Completed · Phase 1
Conditions studied: Healthy
In brief
The main purpose of this study is to conduct blood tests to measure how much LY3537982 is in the bloodstream and how the body handles and eliminates LY3537982 in healthy participants. This study will involve a single dose of 14C radiolabeled LY3537982. This means that a radioactive tracer substance, C14, will be incorporated into the study drug LY3537982 to investigate the study drug and its breakdown products and to find out how much of these passes from blood into urine, feces and expired air. The study will also evaluate the safety and tolerability of LY3537982. The study will be conducted in two parts. The study will last up to 71 days and 61 days for part 1 and 2, respectively.
Key facts
- Study ID
- NCT05901311
- Run by
- Eli Lilly and Company
- People needed
- 16
- Starts
- 2023-06-05
- Expected to finish
- 2023-08-10
- Last updated by the study team
- 2024-11-08
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male and female participants in good health, determined by no clinically significant findings from medical history, physical examination as assessed by the investigator.
- Have a body mass index within the range 18.5 to 32.0 kilograms per meter squared (kg/m²)
- Female participants of non-childbearing potential and male participants who follow standard contraceptive methods.
You may not qualify if…
- History or presence of any diseases or conditions of clinical significance by the Investigator (or designee) and/or Sponsor
- Known ongoing alcohol and/or drug abuse within 2 years prior to Screening
- History of significant hypersensitivity, intolerance, or allergy to any drug compound, food, or other substance, unless approved by the Investigator
Where it is running
- Labcorp Clinical Research Unit Inc. — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.